Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) — Boston, Massachusetts

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Neoplasm, Pituitary Neoplasm, Nelson Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5)?

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) conducted?

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) has 1 clinical trials on record. Their work covers Pancreatic Neoplasm, Pituitary Neoplasm, Nelson Syndrome.

Is Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) accredited by Crixeo Health?

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.